Polypeptides having lysozyme activity and compositions comprising it
US-10119130-B2 · Nov 6, 2018 · US
US10829751B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10829751-B2 |
| Application number | US-201816140941-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2018 |
| Priority date | Nov 25, 2011 |
| Publication date | Nov 10, 2020 |
| Grant date | Nov 10, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to isolated polypeptides having lysozyme activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Opening claim text (preview).
The invention claimed is: 1. A method of feeding an animal, comprising administering a polypeptide having lysozyme activity to the animal, wherein the polypeptide has at least 90% sequence identity to the polypeptide of amino acids 1 to 208 of SEQ ID NO: 8. 2. The method of claim 1 , wherein the polypeptide has at least 92% sequence identity to the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8. 3. The method of claim 1 , wherein the polypeptide has at least 95% sequence identity to the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8. 4. The method of claim 1 , wherein the polypeptide has at least 97% sequence identity to the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8. 5. The method of claim 1 , wherein the polypeptide is encoded by a polynucleotide that hybridizes under high stringency conditions with the mature polypeptide coding sequence of SEQ ID NO: 3 or SEQ ID NO: 7, or the full-length complement of thereof, and has at least 90% sequence identity to the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8. 6. The method of claim 1 , wherein the polypeptide is a variant of the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8, comprising a substitution, deletion, and/or insertion at one or more positions, and has at least 90% sequence identity to the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8. 7. The method of claim 1 , wherein the polypeptide is a fragment of the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8, which has lysozyme activity and has at least 90% sequence identity to the polypeptide sequence of amino acids 1 to 208 of SEQ ID NO: 8. 8. The method of claim 1 , wherein the polypeptide comprises amino acids 1 to 208 of SEQ ID NO: 8. 9. The method of claim 1 , wherein the polypeptide consists of amino acids 1 to 208 of SEQ ID NO: 8. 10. The method of claim 1 , wherein the animal is selected from the group consisting of sheep, goats, cattle, deer, pigs or swine, poultry; horses, and fish. 11. The method of claim 1 , wherein the animal is selected from the group consisting of beef cattle, cows, and young calves. 12. The method of claim 1 , wherein the animal is selected from the group consisting of geese, turkeys, ducks and chicken. 13. The method of claim 1 , wherein the animal is selected from the group consisting of broilers, chicks and layers. 14. The method of claim 1 , wherein the administering of the polypeptide having lysozyme activity improves animal performance. 15. The method of claim 1 , wherein the administering of the polypeptide having lysozyme activity suppresses growth or intestinal colonization of a viral pathogen, parasitic pathogen or bacterial pathogen. 16. The method of claim 15 , wherein the administering of the polypeptide having lysozyme activity suppresses growth or intestinal colonization of coccidian protozoa, Eimeria maxima , or Eimeria mitis. 17. The method of claim 15 , wherein the administering of the polypeptide having lysozyme activity suppresses growth or intestinal colonization of Clostridium perfringens, Escherichia coli, Campylobacter coli, C. hyointestinalis, C. jejuni, Yersinia ssp., Treponema suis, Brachyspira hyodysenteriae, Lawsonia intracellularis or Salmonella. 18. The method of claim 15 , wherein the animal is chicken and the administering of the polypeptide having lysozyme activity suppresses growth or intestinal colonization of Clostridium perfringens. 19. The method of claim 1 , wherein the polypeptide having lysozyme activity is administered to the animal in an animal feed or animal feed additive, which comprises at least one fat-soluble vitamin, and/or at least one water soluble vitamin, and/or at least one trace mineral, and/or at least one macro mineral. 20. The method of claim 19 , wherein the animal feed or animal feed additive further comprises at least one other enzyme selected from the group consisting of phytase (EC 3.1.3.8 or 3.1.3.26); xylanase (EC 3.2.1.8); galactanase (EC 3.2.1.89); alpha-galactosidase (EC 3.2.1.22); protease (EC 3.4), phospholipase A1 (EC 3.1.1.32); phospholipase A2 (EC 3.1.1.4); lysophospholipase (EC 3.1.1.5); phospholipase C (3.1.4.3); phospholipase D (EC 3.1.4.4); and amylase. 21. The method of claim 19 , wherein the animal feed or animal feed additive further comprises maize, sorghum, wheat, barley, oats, soybean meal, fish meal, meat and bone meal; and/or whey.
Alternative feeds for fish, e.g. in aquacultures · CPC title
Inorganic substances, e.g. oligoelements · CPC title
containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase · CPC title
Genes encoding for enzymes or proenzymes · CPC title
Lysis of microorganisms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.